UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Antiviral therapy, 2013-01, Vol.18 (8), p.1033-1035

2013

Volltextzugriff (PDF)

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Antiviral therapy, 2008, Vol.13 (1), p.103-107

2008

Volltextzugriff (PDF)

Management and treatment of chronic hepatitis C in HIV patients

Seminars in liver disease, 2012-05, Vol.32 (2), p.138-146

2012

Volltextzugriff (PDF)

Management of hepatitis B virus co-infection on and off antiretroviral therapy

Current HIV/AIDS reports, 2008-05, Vol.5 (2), p.86-93

2008

Volltextzugriff (PDF)

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Liver international, 2013-10, Vol.33 (9), p.1357-1362

2013

Volltextzugriff (PDF)

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Antiviral therapy, 2012-01, Vol.17 (5), p.921-926

2012

Volltextzugriff (PDF)

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1246-1249

2012

Volltextzugriff (PDF)

Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C

Journal of antimicrobial chemotherapy, 2010-03, Vol.65 (3), p.543-547

2010

Volltextzugriff (PDF)

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

Journal of antimicrobial chemotherapy, 2008-01, Vol.61 (1), p.200-205

2008

Volltextzugriff (PDF)

Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

Journal of antimicrobial chemotherapy, 2008-03, Vol.61 (3), p.699-704

2008

Volltextzugriff (PDF)

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

Journal of clinical virology, 2012-09, Vol.55 (1), p.58-61

2012

Volltextzugriff (PDF)

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir

Antiviral therapy, 2008-01, Vol.13 (3), p.429-437

2008

Volltextzugriff (PDF)

Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells

AIDS research and human retroviruses, 2012-07, Vol.28 (7), p.656-659

2012

Volltextzugriff (PDF)

Predicted effect of direct acting antivirals in the current HIV―HCV-coinfected population in Spain

Antiviral therapy, 2012-01, Vol.17 (3), p.571-575

2012

Volltextzugriff (PDF)

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

Journal of clinical virology, 2013-10, Vol.58 (2), p.391-395

2013

Volltextzugriff (PDF)

Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation

Antiviral therapy, 2009-01, Vol.14 (2), p.187-193

2009

Volltextzugriff (PDF)

Short communication: use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapy

AIDS research and human retroviruses, 2011-10, Vol.27 (10), p.1043-1045

2011

Volltextzugriff (PDF)

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

Journal of hepatology, 2008-12, Vol.49 (6), p.916-922

2008

Volltextzugriff (PDF)

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

Antiviral therapy, 2010-01, Vol.15 (6), p.881-886

2010

Volltextzugriff (PDF)

Human immunodeficiency virus infection and viral hepatitis

Enfermedades infecciosas y microbiologia clinica, 2011-11, Vol.29 (9), p.691

2011

Volltextzugriff (PDF)

Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy

Antiviral therapy, 2014-01, Vol.19 (3), p.287-292

2014

Volltextzugriff (PDF)

Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring

AIDS research and human retroviruses, 2008-06, Vol.24 (6), p.821-825

2008

Volltextzugriff (PDF)

Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy

The Journal of infection, 2011-11, Vol.63 (5), p.382-390

2011

Volltextzugriff (PDF)

Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C

AIDS research and human retroviruses, 2010-04, Vol.26 (4), p.419-424

2010

Volltextzugriff (PDF)

The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring

Therapeutic drug monitoring, 2010-04, Vol.32 (2), p.242-244

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Zeitschrift / SerieJournal Of Acquired Immune Deficiency Syndromes

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(28)
Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Female
(24)
Adult
(23)
Infectious Diseases
(23)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Human Viral Diseases
(19)
Middle Aged
(19)
Viral Diseases
(19)
Hiv Infections - Complications
(18)
Hiv Infections - Drug Therapy
(18)
Virology
(15)
Human Immunodeficiency Virus
(14)
Pharmacology & Pharmacy
(14)
Pharmacology. Drug Treatments
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)
Hiv Infections - Virology
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Management and treatment of chronic hepatitis C in HIV patients

Management of hepatitis B virus co-infection on and off antiretroviral therapy

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial

Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir

Short communication high risk of endothelial dysfunction in HIV individuals may result from deregulation of circulating endothelial cells and endothelial progenitor cells

Predicted effect of direct acting antivirals in the current HIV―HCV-coinfected population in Spain

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation

Short communication: use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapy

Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy

Human immunodeficiency virus infection and viral hepatitis

Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy

Switch from ritonavir-boosted to unboosted atazanavir guided by therapeutic drug monitoring

Soluble markers of inflammation are associated with Framingham scores in HIV-infected patients on suppressive antiretroviral therapy

Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C

The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring

Aktive Filter

Suchergebnisse filtern